BeStock  
Stocks › Biotechnology › RARE

Ultragenyx Pharmaceutical RARE

US equityMarket cap rank #2801Biotechnology
$16.48 −$0.74 (-4.30%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.50 +0.12%
Open$16.94
Prev close$17.22
Day range$16.43 – $17.35
Volume3.01M
Market cap$1.68B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-3.1x
CheapRich

Near the top of its 5-year range · 96th percentile, 5-year average -6.0x

Price / book-4.4x
CheapRich

Near the bottom of its 5-year range · 15th percentile, 5-year average 30.2x

Price / sales2.2x
CheapRich

Near the bottom of its 5-year range · 3rd percentile, 5-year average 7.8x

#2707 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-17x-12x-7x-1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$20.84
Price vs. fair value-20.9%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB -4.36 – 30.22 15% (cheaper than usual) –
PE -3.11 -73.64 -5.96 96% (pricier than usual) –
PS 2.25 1.73 7.77 3% (cheaper than usual) #2707 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RARE.

Sign in to join the discussion.

Scroll to Top